<DOC>
	<DOCNO>NCT00171496</DOCNO>
	<brief_summary>The purpose study evaluate impact tacrolimus cyclosporine microemulsion glucose metabolism kidney transplant recipient efficacy safety prevent organ rejection</brief_summary>
	<brief_title>Evaluation Cyclosporine Microemulsion Tacrolimus Rate New Onset Diabetes Mellitus Kidney Transplantation Recipients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>First second transplant , cadaveric living donor Multiorgan dual kidney transplant Panel reactive antibody &gt; 50 % Other protocoldefined inclusion/exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Kidney transplant , adult , NODM , immunosuppressant</keyword>
</DOC>